Curaleaf Holdings Inc (CURA)
CNSX 
Summary
CURA Chart
How Much Upside is Left in Curaleaf Holdings, Inc. (CURLF)? Wall Street Analysts Think 40.63%
The mean of analysts' price targets for Curaleaf Holdings, Inc. (CURLF) points to a 40.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Curaleaf launches hostile bid for Aurora Cannabis
Curaleaf Hldgs Inc. (OTCQX:CURLF) has launched a hostile bid to acquire Aurora Cannabis Inc (TSX:ACB, NASDAQ:ACB), offering Aurora shareholders a combination of Curaleaf shares and cash that values the proposal at US$4 per Aurora share, as it seeks to combine the companies' international cannabis operations. Under the proposed transaction, Aurora shareholders would receive 0.3463 Curaleaf shares plus US$0.75 in cash for each Aurora share.
Tilray Brands stock rises as Curaleaf plots hostile takeover for Aurora
Tilray Brands stock rose by nearly 4% as investors rotated to companies in the cannabis industry after a report said that Curaleaf was planning a hostile bid for Aurora Cannabis. TLRY rose to an intraday high of 4.70, up by 25% from its lowest level this year.
Curaleaf Holdings Inc (CURA) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Curaleaf Holdings Inc ever had a stock split?
Curaleaf Holdings Inc Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Boris Alexis Jordan CEO | CNSX Exchange | CA23126M1023 ISIN |
| US Country | 5,554 Employees | - Last Dividend | 5 Jun 2026 Last Split | - IPO Date |
Overview
Curaleaf Holdings, Inc. stands as a prominent cannabis operator within the United States, encompassing its business operations into two main segments: Domestic Operations and International Operations. As a company, it is engaged in the cultivation, production, and sale of cannabis and related products, catering to both the retail and wholesale markets. With its headquarters based in New York, New York, Curaleaf has established itself as a key player in the industry, providing a wide range of cannabis products to a diverse clientele, while also spearheading initiatives in hemp-based product offerings and innovative cannabinoid applications.
Products and Services
- Flower, Pre-rolls, Flower Pots, and Dry-Herb Vaporizer Cartridges
Curaleaf offers an extensive selection of cannabis flower products, including pre-rolls for convenience, flower pots for personal use, and dry-herb vaporizer cartridges for a modern smoking experience. These products are designed to meet the varied preferences of consumers, offering high-quality cannabis strains cultivated under stringent standards.
- Concentrates for Vaporizing
The company provides a variety of concentrates specifically designed for vaporizing, such as pre-filled vaporizer cartridges and disposable vaporizer pens. These products offer a discreet and efficient way to consume cannabis, with options available in different strains and potencies to cater to individual needs and preferences.
- Concentrates for Dabbing
For consumers who prefer dabbing, Curaleaf presents a selection of concentrates including mints, distillate droppers, and more. These products allow for a potent and customizable cannabis experience, suitable for both seasoned consumers and those looking to explore concentrated forms of cannabis.
- Mints, Topical Balms and Lotions, Tinctures, Lozenges, Capsules, and Edibles
Beyond traditional cannabis products, Curaleaf has expanded its portfolio to include a variety of alternative formats such as mints, topical balms and lotions for external use, tinctures and lozenges for easy consumption, capsules for precise dosing, and a wide range of edibles. These products are designed to offer consumers diverse ways to experience the benefits of cannabis, with a focus on convenience, discretion, and efficacy.
- Hemp-Based Products and Cannabinoids
Curaleaf also engages in the production and sale of hemp-based products and cannabinoids like cannabidiol (CBD) and cannabigerol (CBG). These offerings cater to the growing demand for non-psychoactive cannabinoids, known for their therapeutic benefits, and are available in various formulations to meet consumer needs in wellness and medicinal contexts.
